Cargando…

HDAC inhibitors induce LIFR expression and promote a dormancy phenotype in breast cancer

Despite advances in breast cancer treatment, residual disease driven by dormant tumor cells continues to be a significant clinical problem. Leukemia inhibitory factor receptor (LIFR) promotes a dormancy phenotype in breast cancer cells and LIFR loss is correlated with poor patient survival. Herein w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Clements, Miranda E., Holtslander, Lauren, Edwards, Courtney, Todd, Vera, Dooyema, Samuel D.R., Bullock, Kennady, Bergdorf, Kensey, Zahnow, Cynthia A., Connolly, Roisin M., Johnson, Rachelle W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8403155/ https://www.ncbi.nlm.nih.gov/pubmed/34247191 http://dx.doi.org/10.1038/s41388-021-01931-1

Ejemplares similares

Select HDAC Inhibitors Enhance Osteolysis and Bone Metastasis Outgrowth but Can Be Mitigated With Bisphosphonate Therapy
por: Clements, Miranda E, et al.
Publicado: (2023)

Induction of LIFR confers a dormancy phenotype in breast cancer cells disseminated to the bone marrow
por: Johnson, Rachelle W., et al.
Publicado: (2016)

LIFR inhibition enhances the therapeutic efficacy of HDAC inhibitors in triple negative breast cancer
por: Li, Mengxing, et al.
Publicado: (2021)

Targeting LIF/LIFR signaling in cancer
por: Viswanadhapalli, Suryavathi, et al.
Publicado: (2021)

From Good to Bad: The Opposing Effects of PTHrP on Tumor Growth, Dormancy, and Metastasis Throughout Cancer Progression
por: Edwards, Courtney M., et al.
Publicado: (2021)

High-throughput drug screening of fine-needle aspiration-derived cancer organoids
por: Bergdorf, Kensey, et al.
Publicado: (2020)

Utilizing Three-Dimensional Culture Methods to Improve High-Throughput Drug Screening in Anaplastic Thyroid Carcinoma
por: Bergdorf, Kensey, et al.
Publicado: (2022)

Stüve-Wiedemann syndrome: LIFR and associated cytokines in clinical course and etiology
por: Mikelonis, Dawn, et al.
Publicado: (2014)

Inhibition of LIFR Blocks Adiposity-Driven Endometrioid Endometrial Cancer Growth
por: Blankenship, Logan, et al.
Publicado: (2022)

LIF/LIFR oncogenic signaling is a novel therapeutic target in endometrial cancer
por: Tang, Weiwei, et al.
Publicado: (2021)

Long Noncoding RNA LIFR-AS1: A New Player in Human Cancers
por: Bai, Zhiqun, et al.
Publicado: (2022)

LncRNA LIFR‐AS1 overexpression suppressed the progression of serous ovarian carcinoma
por: Liu, Fang, et al.
Publicado: (2022)

Downregulation of circLIFR exerts cancer-promoting effects on hepatocellular carcinoma in vitro
por: Ji, Jingzhang, et al.
Publicado: (2022)

Immunofluorescent staining of cancer spheroids and fine-needle aspiration-derived organoids
por: Bergdorf, Kensey N., et al.
Publicado: (2021)

Obtaining patient-derived cancer organoid cultures via fine-needle aspiration
por: Phifer, Courtney J., et al.
Publicado: (2020)

High LIFr expression stimulates melanoma cell migration and is associated with unfavorable prognosis in melanoma
por: Guo, Hongwei, et al.
Publicado: (2015)

The LIFR-targeting small molecules EC330/EC359 are potent ferroptosis inducers
por: Feng, Chang-Zhou, et al.
Publicado: (2022)

Suppressing MDSC Recruitment to the Tumor Microenvironment by Antagonizing CXCR2 to Enhance the Efficacy of Immunotherapy
por: Bullock, Kennady, et al.
Publicado: (2021)

The ILEI/LIFR complex induces EMT via the Akt and ERK pathways in renal interstitial fibrosis
por: Zhou, Jieqing, et al.
Publicado: (2022)

Cynaropicrin Shows Antitumor Progression Potential in Colorectal Cancer Through Mediation of the LIFR/STATs Axis
por: Zheng, Dandan, et al.
Publicado: (2021)

A CD25(−) Positive Population of Activated B1 Cells Expresses LIFR and Responds to LIF
por: Tumang, Joseph R., et al.
Publicado: (2011)

LIFR-α-dependent adipocyte signaling in obesity limits adipose expansion contributing to fatty liver disease
por: Guo, Tong, et al.
Publicado: (2021)

Pan-cancer analysis identifies LIFR as a prognostic and immunological biomarker for uterine corpus endometrial carcinoma
por: Zhang, Fang, et al.
Publicado: (2023)

Synovial tissue quantitative proteomics analysis reveals paeoniflorin decreases LIFR and ASPN proteins in experimental rheumatoid arthritis
por: Yang, Shu, et al.
Publicado: (2018)

TGFβ promotes breast cancer stem cell self-renewal through an ILEI/LIFR signaling axis
por: Woosley, Alec N., et al.
Publicado: (2019)

A targetable LIFR−NF-κB−LCN2 axis controls liver tumorigenesis and vulnerability to ferroptosis
por: Yao, Fan, et al.
Publicado: (2021)

LncRNA GAS5 Suppresses Colorectal Cancer Progress by Target miR-21/LIFR Axis
por: Xie, Juan, et al.
Publicado: (2022)

Whole exome sequencing identifies KIF26B, LIFR and LAMC1 mutations in familial vesicoureteral reflux
por: Bartik, Zsuzsa I., et al.
Publicado: (2022)

CCAAT/enhancer binding proteins in normal mammary development and breast cancer
por: Zahnow, Cynthia A
Publicado: (2002)

LIFR-AS1 modulates Sufu to inhibit cell proliferation and migration by miR-197-3p in breast cancer
por: Xu, Fangfang, et al.
Publicado: (2019)

Histone methyltransferase KMT2D sustains prostate carcinogenesis and metastasis via epigenetically activating LIFR and KLF4
por: Lv, Shidong, et al.
Publicado: (2017)

lncRNA LIFR-AS1 inhibits gastric carcinoma cell proliferation, migration and invasion by sponging miR-4698
por: Zhao, Jiangqiao, et al.
Publicado: (2021)

OSMR deficiency aggravates pressure overload-induced cardiac hypertrophy by modulating macrophages and OSM/LIFR/STAT3 signalling
por: Feng, Yizhou, et al.
Publicado: (2023)

Dormancy in cancer
por: Endo, Hiroko, et al.
Publicado: (2019)

CircLIFR synergizes with MSH2 to attenuate chemoresistance via MutSα/ATM-p73 axis in bladder cancer
por: Zhang, Hui, et al.
Publicado: (2021)

Circular RNA circARPP21 Acts as a Sponge of miR-543 to Suppress Hepatocellular Carcinoma by Regulating LIFR
por: Gu, Yichao, et al.
Publicado: (2021)

PCBP1 regulates LIFR through FAM3C to maintain breast cancer stem cell self-renewal and invasiveness
por: Streitfeld, William S., et al.
Publicado: (2023)

The premise of personalized immunotherapy for cancer dormancy: Cancer dormancy vaccines
por: Manjili, Masoud H.
Publicado: (2020)

Utilizing cell line-derived organoids to evaluate the efficacy of a novel LIFR-inhibitor, EC359 in targeting pancreatic tumor stroma
por: Hall, Bradley R., et al.
Publicado: (2019)

A mandatory role of nuclear PAK4-LIFR axis in breast-to-bone metastasis of ERα-positive breast cancer cells
por: Li, Yanshu, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_he92g6gn1bquld25vg5jd5n2o6